Generali Investments CEE’s AstraZeneca AZN Stock Holding History

Generali Investments CEE’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.59M	Sell	13,830 -1,498	-10%	-$282K	0.12%	179
2026 Q1	$2.98M	Buy	+15,328	New	+$2.96M	0.16%	171
2025 Q4	–	Sell	-10,550	Closed	-$1.62M	–	394
2025 Q3	$1.62M	Hold	10,550	–	–	0.12%	190
2025 Q2	$1.47M	Hold	10,550	–	–	0.12%	197
2025 Q1	$1.55M	Hold	10,550	–	–	0.14%	185
2024 Q4	$1.38M	Buy	+10,550	New	+$1.48M	0.14%	177

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Generali Investments CEE's AZN Position: Q2 2026 in Review

Generali Investments CEE reduced its AstraZeneca (AZN) stake by 9.8% in Q2 2026, selling an estimated $282K and leaving 13,830 shares worth $2.59M. The position accounts for 0.12% of the portfolio, ranked #179.

Generali Investments CEE first reported a position in AZN in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.98M in Q1 2026. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Generali Investments CEE held 13,830 shares of AstraZeneca worth $2.59M as of Q2 2026.
Generali Investments CEE sold 1,498 AstraZeneca shares in Q2 2026, an estimated $282K.
AstraZeneca made up 0.12% of Generali Investments CEE's portfolio in Q2 2026, its #179 holding.
Generali Investments CEE first reported a position in AstraZeneca in Q4 2024 and has held it in 6 quarters since.
Generali Investments CEE's AstraZeneca position peaked at $2.98M in Q1 2026.
1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Generali Investments CEE's 13F filing for Q2 2026, filed 13 Jul 2026.